Opus Regulatory Inc. will be presenting at the workshop on October 19th on CCDS after TPL with Gerrit-Jan Nijveldt.
Public source
Publisher name
Public post
There are not may global labeling meetings and for sure not in 2026 This is your chance to spend 2 (or 3 days) with labeling experts and listen to presentations and ask…
Company
Opus Regulatory Inc.
Experts in Regulatory Strategy | CMC | Labeling | Ad Promo | Medical Review & Information
- Industry
- Business Consulting and Services
- Location
- Boston, US
- Company size
- 51–200 employees
About Opus Regulatory Inc.
Opus Regulatory is a niche consulting firm headquartered in the Seaport district of Boston. With a team of over 100 full-time, remote-based employees, Opus has built a strong reputation in the pharmaceutical and biotechnology sectors, offering expertise across five core pillars: Regulatory Strategy, CMC, Labeling, Advertising and Promotion, and Medical Review & Medical Information. Our broad service offerings empower clients with the targeted, high-quality expertise they need at any stage of development.
See moreLatest activity
Latest activity from Opus Regulatory Inc.
3 signals
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Qserve Group
Qserve Group is co-presenting a session titled Real-World Evidence: How to Move From Regulatory Buzzword to Valuable Asset alongside Lisa Small PharmD, Daniel Caños, and Erich McGilvreay.
Presence & Recognition
SQA Services, Inc.
SQA Services, Inc. will be in DC next week for the PDA/FDA Joint Regulatory Conference, talking with pharmaceutical quality teams about the FDA 483 gap.
Presence & Recognition
NAMSA
NAMSA biological safety experts will be joined by a guest speaker from the PMDA on October 16 to walk through what each region wants to see regarding biological safety evaluation.
Presence & Recognition
MAIN5
MAIN5 is hosting a presentation by Matthias Sijtstra on Beyond the IDMP Deadline: Why Product Data Only Stays Good If Someone Uses It at the Global Pharmaceutical Regulatory Affairs Summit in Brussels on 29 September 2026.
Presence & Recognition
Fusion Pharma Limited